Enzymatica AB: Enzymatica - publication of the annual report 2016

Enzymatica AB: Enzymatica - publication of the annual report 2016

ID: 535110

(Thomson Reuters ONE) -


Press release
Lund, 6 April, 2017



Enzymatica - publication of the annual report 2016

Enzymatica announces today that the annual report 2016 is available on the
company's web site
www.enzymatica.se. The annual report is produced in Swedish. A brief English
version of the annual report is available on the English version of the website.



For more information, please contact:
Fredrik Lindberg, CEO Enzymatica AB
Tel: +46 708-86 53 70 | E-post: fredrik.lindberg(at)enzymatica.com

Jörgen Rexö, VP Legal & Communications Enzymatica
Tel: 0708-19 22 82 | E-post: jorgen.rexo(at)enzymatica.com


About Enzymatica AB
Enzymatica is a life science company who develops and sells medical device
products against infectious-related diseases. Over a short period the company
has developed a unique oral spray for colds, ColdZyme®, and launched it on eight
markets. The product has become one of the leading articles for colds in Swedish
pharmacies. Enzymatica's strategy is to continue growing by strengthening its
position in existing markets and to expand to more geographical markets through
well-established partners. The company is headquartered in Lund, Sweden and is
listed on Nasdaq First North. For more information, please visit
www.enzymatica.com.

Enzymatica's certified advisor is Erik Penser Bankaktiebolag.



PR Enzymatica releases annual report 2016:
http://hugin.info/160850/R/2094609/792037.pdf



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Enzymatica AB via GlobeNewswire






Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Galapagos increases share capital through warrant exercises Successful Galenica Santé IPO, Galenica Group becomes Vifor Pharma Group
Bereitgestellt von Benutzer: hugin
Datum: 06.04.2017 - 21:33 Uhr
Sprache: Deutsch
News-ID 535110
Anzahl Zeichen: 2048

contact information:
Town:

Lund



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 150 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Enzymatica AB: Enzymatica - publication of the annual report 2016"
steht unter der journalistisch-redaktionellen Verantwortung von

Enzymatica AB (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Enzymatica AB



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z